image

The best stocks to buy since 1993

Latest issue now available

AlphaFX

October 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • AFX
  • Price:
  • 1700p
Since March 2021, FY22 forecasts have been upgraded five times and by 36% prior to H1 results so there were no real surprises in the results when I spoke to chief executive Morgan Tillbrook. Revenue grew 35% to £46.1m including £1.4m of recharged interest. Pretax profit (after absorbing the cost of adding 74 new employees and further build out of its tech stack) was up 16% to £17.8m, for eps up 21% to 33.3p.  Underlying pretax margin came in at 39% reflecting investment in staff and technology. But a keynote is that deferred revenue from account fees are recognised over the next 12 months  - add those back and the margin would have been closer to 45%.FXRM grew sales 31% to £32.1m driven by a 22% jump in client numbers to 975 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe